Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button


Home > Press > Nanostart-held Curiox Biosystems wins Emerging Company award

* "Emerging Company of the Year in Asia Pacific" in biomedical sciences
* "Curiox is a potential industry leader within 10 years"
* Expanding in USA, Europe and Japan

Nanostart-held Curiox Biosystems wins Emerging Company award

Singapore / Frankfurt | Posted on March 16th, 2010

Curiox was awarded "Emerging Company of the Year 2010 in Asia Pacific", on 12th March, by BioSpectrum Asia. BioSpectrum Asia is a leading B2B media platform covering the life sciences industry in the Asia Pacific region.

Curiox and other Asia Pacific companies were assessed on the basis of their achievements and potential for future growth to determine companies that shall emerge as industry leaders, in the biomedical science and biotechnology sectors, in the coming decade. BioSpectrum's team of industry experts evaluated all aspects of the organizations' performance and public profile, prior to nominating Curiox as the winner of the award in the sector biomedical sciences. The award was given to five more companies from other sectors in life sciences and medical technologies.

Curiox's "Emerging Company of the Year" award comes hot on the heels of Curiox's LabAutomation2010 "Innovation AveNEW" award, earlier this year; as one of the industry's most innovative laboratory automation technology. This magnitude of worldwide industry acceptance and excitement for is welcomed by the young Singaporean start-up Curiox; and comes at a crucial time as Curiox begins to expand its products to overseas markets.

"It is truly an honour to be selected with top companies in Asia who have been around much longer than Curiox. These awards demonstrate to our customers, partners and competitors that our DropArray™ technology is truly innovative, and is recognized by industry experts (on a global scale) to be beneficial and potentially disruptive to the laboratory automation industry," comments Curiox's CEO Dr Namyong Kim.

Curiox's patent-pending DropArray™ technology provides a next-generation "wall-less" microtiter platform, and complimentary washing instrument, to provide researchers with better quality of data, 10 - 50 times savings in sample and reagent consumption, and up to 60 % assay time reduction. Additionally, DropArray™ technology promotes integration with liquid handling systems by maintainaining reproducibility and compatibility with existing microtiter plate detection systems.

Curiox Biosystems intends to penetrate the United States, European and Japanese laboratory markets this year through strategic partnerships and distributors.

According to BioSpectrum Asia, it has a readership of over 150,000 (including print magazine, online-edition and website) of which a large majority represent key decision makers in the Pharma and Biotech industry.

The Nanostart Singapore Early Stage Venture Fund I holds almost 19% in Curiox Biosystems.

This notice constitutes neither an offer to sell nor a solicitation of offers to purchase or subscribe to securities. There will be no public offering of securities of Nanostart AG in conjunction with the existing listing of its shares in the "Entry Standard" segment of the regulated unofficial market (Freiverkehr) on the Frankfurt Stock Exchange. This notice does not constitute a securities prospectus. Neither this notice nor the information contained within is intended for direct or indirect distribution within the United States of America, Canada, Australia or Japan.


About Nanostart AG
Nanostart AG is the world’s leading nanotechnology investment company. The Frankfurt-based company provides venture capital financing for nanotechnology companies in various growth phases. It also provides the benefits of its experience and expertise to developers of financial instruments and to investors in the nanotechnology sector. For further information about the company, please visit

About Curiox Biosystems Pte Ltd
Curiox Biosystems has a vision to accelerate the progress of life sciences and drug discovery through better miniaturization. Curiox is a bioinstrumentation company enabling the miniaturization of heterogeneous bioassay for researchers working in life sciences, drug discovery, and diagnostics. Curiox’s patented miniaturization platform, DropArray™, provides up to 1,000 times savings in sample and reagent consumption, and up to 10 times reduction in assay time. The company is located in Singapore, the biomedical hub of Southeast Asia. The company is a spin-off from Institute of Bioengineering and Nanotechnology (IBN) backed primarily by Nanostart and Exploit Technologies, the commercializing arm of Singapore’s Agency for Science, Technology and Research (A*STAR). For further information, please visit

For more information, please click here

Media contact:
Nanostart AG
Public Relations
Dr. Hans Joachim Dürr
Goethestrasse 26-28
D-60313 Frankfurt
phone: +49 (0)69-21 93 96 111
fax: +49 (0)69-21 93 96 122

Copyright © Nanostart AG

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Chemical cages: New technique advances synthetic biology February 10th, 2016

New thin film transistor may lead to flexible devices: Researchers engineer an electronics first, opening door to flexible electronics February 10th, 2016

Making sense of metallic glass February 9th, 2016

Electron's 1-D metallic surface state observed: A step for the prediction of electronic properties of extremely-fine metal nanowires in next-generation semiconductors February 9th, 2016


Harris & Harris Group Portfolio Company, Magic Leap, Raises $793.5 Million in New Funding February 3rd, 2016

Israel: A Nanotech Superpower: Did you know that Israel is a hotbed for nanotechnology research and development? February 1st, 2016

PEN Inc. Announces 1-for-180 Reverse Stock Split January 27th, 2016

Nanometrics to Announce Fourth Quarter and Full Year Financial Results on February 2, 2016 January 13th, 2016


Chemical cages: New technique advances synthetic biology February 10th, 2016

New thin film transistor may lead to flexible devices: Researchers engineer an electronics first, opening door to flexible electronics February 10th, 2016

Superconductivity: Footballs with no resistance - Indications of light-induced lossless electricity transmission in fullerenes contribute to the search for superconducting materials for practical applications February 9th, 2016

SUNY Poly and GLOBALFOUNDRIES Announce New $500M R&D Program in Albany To Accelerate Next Generation Chip Technology: Arrival of Second Cutting Edge EUV Lithography Tool Launches New Patterning Center That Will Generate Over 100 New High Tech Jobs at SUNY Poly February 9th, 2016


Making sense of metallic glass February 9th, 2016

Chiral magnetic effect generates quantum current: Separating left- and right-handed particles in a semi-metallic material produces anomalously high conductivity February 8th, 2016

Metal oxide sandwiches: New option to manipulate properties of interfaces February 8th, 2016

Researchers discover new phase of boron nitride and a new way to create pure c-BN February 5th, 2016


Chemical cages: New technique advances synthetic biology February 10th, 2016

Nanoparticle therapy that uses LDL and fish oil kills liver cancer cells February 9th, 2016

Leading bugs to the death chamber: A kinder face of cholesterol February 8th, 2016

UTHealth research looks at nanotechnology to help prevent preterm birth February 7th, 2016

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project

Car Brands
Buy website traffic